Diaceutics announced the founder and chief executive of the company is stepping down after nearly two decades at the helm. Peter Keeling co-founded the company in 2005, growing it from a small consulting service provider to a listed company which employs 161 people across Europe and North America. He will step down as chief executive in January, with chief information officer Ryan Keeling becoming chief executive-designate with immediate effect.

Ryan, who is Peter?s nephew, joined Diaceutics in 2006 and became a member of the board of directors following the company's listing on the AIM in 2019.